ARV-393 is Arvinas’ investigational PROteolysis TArgeting Chimera (PROTAC) degrader targeting the B-cell lymphoma 6 protein (BCL6), a transcriptional repressor and major driver of B-cell lymphomas.

Monsanto, which on April 9 petitioned the U.S. Supreme Court to review its federal preemption defense in a Missouri case, ...

The former midfielder, who played for multiple professional teams in England, was remembered as "brave and courageous" in a ...

Dianne Callahan, a three-time survivor of non-Hodgkin lymphoma and survivor of breast cancer, launched the Survivor Strut fashion show in 2008, after she achieved remission from her first fight ...

Former Manchester United academy player and Rochdale star Joe Thompson has died at the age of 36. Thompson, who retired from ...

But looking back on late 2018 to '19, around the time she was diagnosed with stage 3 Hodgkin's lymphoma, "that was one whirlwind of a year," she says. Demac, who turns 33 three days after the ...

In January 2023, Hendriks announced that he had been diagnosed with non-Hodgkin lymphoma and was undergoing treatment ahead of the MLB season. He underwent his last chemotherapy treatment that ...

Autologous-hematopoietic Stem Cell Transplantation for Diffuse Large B-cell Non-Hodgkin Lymphoma Despite recent advances in the treatment of non-Hodgkin lymphoma (NHL), some patients with advanced ...

From Beth Jordache (Anna Friel) and Margaret Clemence’s (Nicola Stephenson) first kiss in Brookside, to Suki Panesar ( Balvinder Sopal) and Eve Unwin ’s ( Heather Peace) dramatic love affair in ...

Hendriks allowed two runs on three hits while striking out one over one inning in Sunday's 8-4 loss to the White Sox.

Steve brings deep experience in strategic transactions to Werewolf at this critical time,” said Daniel J. Hicklin, Ph.D., President and Chief Executive Officer of Werewolf Therapeutics. “Werewolf is ...